Opposing actions of hippocampus TNFα receptors on limbic seizure susceptibility

Experimental Neurology

Volumn 247, Issue , 2013, Pages 429-437

  Weinberg, Marc S ^a   Blake, Bonita L ^a   McCown, Thomas J ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Adeno associated virus; Epilepsy; Neuroimmune; Neuropathology; Seizures; TNF receptors; TNF alpha

Indexed keywords

TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA RECEPTOR; TUMOR NECROSIS FACTOR ALPHA RECEPTOR 1; TUMOR NECROSIS FACTOR ALPHA RECEPTOR 2; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD BRAIN BARRIER; CELL ACTIVATION; COMPLEX PARTIAL SEIZURE; CONTROLLED STUDY; DISEASE PREDISPOSITION; HIPPOCAMPAL CA3 REGION; IMMUNE RESPONSE; MALE; MICROGLIA; NERVE CELL NECROSIS; NERVOUS SYSTEM INFLAMMATION; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; RECEPTOR UPREGULATION;

AAV; ADENO-ASSOCIATED VIRUS; EPILEPSY; NEUROIMMUNE; NEUROPATHOLOGY; SEIZURES; TNF RECEPTORS; TNF-Α; TNF-ALPHA; TNFR; TUMOR NECROSIS FACTOR RECEPTOR; TUMOR NECROSIS FACTOR-ALPHA;

ANALYSIS OF VARIANCE; ANIMALS; ANTIGENS, CD11B; CELL LINE, TRANSFORMED; GENE EXPRESSION REGULATION; GREEN FLUORESCENT PROTEINS; HIPPOCAMPUS; HISTOCOMPATIBILITY ANTIGENS CLASS II; HUMANS; KINDLING, NEUROLOGIC; LIMBIC SYSTEM; MALE; NERVE TISSUE PROTEINS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; SEIZURES; TIME FACTORS; TRANSFECTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84881375309     PISSN: 00144886     EISSN: 10902430     Source Type: Journal    
DOI: 10.1016/j.expneurol.2013.01.011     Document Type: Article

References (33)

1. Balosso S., Ravizza T., Perego C., Peschon J., Campbell I.L., De Simoni M.G., Vezzani A. Tumor necrosis factor-alpha inhibits seizures in mice via p75 receptors. Ann. Neurol. 2005, 57:804-812.
2. Bordey A., Sontheimer H. Properties of human glial cells associated with epileptic seizure foci. Epilepsy Res. 1998, 32:286-303.
3. Bruce A.J., Boling W., Kindy M.S., Peschon J., Kraemer P.J., Carpenter M.K., Holtsberg F.W., Mattson M.P. Altered neuronal and microglial responses to excitotoxic and ischemic brain injury in mice lacking TNF receptors. Nat. Med. 1996, 2:788-794.
4. Burger C., Gorbatyuk O.S., Velardo M.J., Peden C.S., Williams P., Zolotukhin S., Reier P.J., Mandel R.J., Muzyczka N. Recombinant AAV viral vectors pseudotyped with viral capsids from serotypes 1, 2, and 5 display differential efficiency and cell tropism after delivery to different regions of the central nervous system. Mol. Ther. 2004, 10:302-317.
5. Childs L.M., Goater J.J., O'Keefe R.J., Schwarz E.M. Effect of anti-tumor necrosis factor-alpha gene therapy on wear debris-induced osteolysis. J. Bone Joint Surg. Am. 2001, 83-A:1789-1797.
6. Choi J., Nordli D.R., Alden T.D., DiPatri A., Laux L., Kelley K., Rosenow J., Schuele S.U., Rajaram V., Koh S. Cellular injury and neuroinflammation in children with chronic intractable epilepsy. J Neuroinflammation 2009, 6:38.
7. Crespel A., Coubes P., Rousset M.C., Brana C., Rougier A., Rondouin G., Bockaert J., Baldy-Moulinier M., Lerner-Natoli M. Inflammatory reactions in human medial temporal lobe epilepsy with hippocampal sclerosis. Brain Res. 2002, 952:159-169.
8. Dedeurwaerdere S., Friedman A., Fabene P.F., Mazarati A., Murashima Y.L., Vezzani A., Baram T.Z. Finding a better drug for epilepsy: antiinflammatory targets. Epilepsia 2012, 53:1113-1118.
9. Gary D.S., Bruce-Keller A.J., Kindy M.S., Mattson M.P. Ischemic and excitotoxic brain injury is enhanced in mice lacking the p55 tumor necrosis factor receptor. J. Cereb. Blood Flow Metab. 1998, 18:1283-1287.
10. Gorbatyuk O.S., Li S., Sullivan L.F., Chen W., Kondrikova G., Manfredsson F.P., Mandel R.J., Muzyczka N. The phosphorylation state of Ser-129 in human alpha-synuclein determines neurodegeneration in a rat model of Parkinson disease. Proc. Natl. Acad. Sci. 2008, 105:763-768.
11. Grieger J.C., Choi V.W., Samulski R.J. Production and characterization of adeno-associated viral vectors. Nat. Protoc. 2006, 1:1412-1428.
12. Hufnagel A., Weber J., Marks S., Ludwig T., De Greiff A., Leonhardt G., Widmann G., Stolke D., Forsting M. Brain diffusion after single seizures. Epilepsia 2003, 44:54-63.
13. Lehtimaki K.A., Keranen T., Huhtala H., Hurme M., Ollikainen J., Honkaniemi J., Palmio J., Peltola J. Regulation of IL-6 system in cerebrospinal fluid and serum compartments by seizures: the effect of seizure type and duration. J. Neuroimmunol. 2004, 152:121-125.
14. Lewis M., Tartaglia L.A., Lee A., Bennett G.L., Rice G.C., Wong G.H., Chen E.Y., Goeddel D.V. Cloning and expression of cDNAs for two distinct murine tumor necrosis factor receptors demonstrate one receptor is species specific. Proc. Natl. Acad. Sci. 1991, 88:2830-2834.
15. Marchi N., Angelov L., Masaryk T., Fazio V., Granata T., Hernandez N., Hallene K., Diglaw T., Franic L., Najm I., Janigro D. Seizure-promoting effect of blood-brain barrier disruption. Epilepsia 2007, 48:732-742.
16. McCown T.J. The future of epilepsy treatment: focus on adeno-associated virus vector gene therapy. Drug News Perspect. 2010, 23:281-286.
17. Minami M., Kuraishi Y., Satoh M. Effects of kainic acid on messenger RNA levels of IL-1 beta, IL-6, TNF alpha and LIF in the rat brain. Biochem. Biophys. Res. Commun. 1991, 176:593-598.
18. Naude P.J., den Boer J.A., Luiten P.G., Eisel U.L. Tumor necrosis factor receptor cross-talk. FEBS J. 2011, 278:888-898.
19. Plata-Salaman C.R., Ilyin S.E., Turrin N.P., Gayle D., Flynn M.C., Romanovitch A.E., Kelly M.E., Bureau Y., Anisman H., McIntyre D.C. Kindling modulates the IL-1beta system, TNF-alpha, TGF-beta1, and neuropeptide mRNAs in specific brain regions. Brain Res. Mol. Brain Res. 2000, 75:248-258.
20. Probert L., Akassoglou K., Pasparakis M., Kontogeorgos G., Kollias G. Spontaneous inflammatory demyelinating disease in transgenic mice showing central nervous system-specific expression of tumor necrosis factor alpha. Proc. Natl. Acad. Sci. 1995, 92:11294-11298.
21. Racine R.J. Modification of seizure activity by electrical stimulation. II. Motor seizure. Electroencephalogr. Clin. Neurophysiol. 1972, 32:281-294.
22. Ravizza T., Gagliardi B., Noe F., Boer K., Aronica E., Vezzani A. Innate and adaptive immunity during epileptogenesis and spontaneous seizures: evidence from experimental models and human temporal lobe epilepsy. Neurobiol. Dis. 2008, 29:142-160.
23. Riazi K., Galic M.A., Kuzmiski J.B., Ho W., Sharkey K.A., Pittman Q.J. Microglial activation and TNFalpha production mediate altered CNS excitability following peripheral inflammation. Proc. Natl. Acad. Sci. 2008, 105:17151-17156.
24. Seiffert E., Dreier J.P., Ivens S., Bechmann I., Tomkins O., Heinemann U., Friedman A. Lasting blood-brain barrier disruption induces epileptic focus in the rat somatosensory cortex. J. Neurosci. 2004, 24:7829-7836.
25. Shinoda S., Skradski S.L., Araki T., Schindler C.K., Meller R., Lan J.Q., Taki W., Simon R.P., Henshall D.C. Formation of a tumour necrosis factor receptor 1 molecular scaffolding complex and activation of apoptosis signal-regulating kinase 1 during seizure-induced neuronal death. Eur. J. Neurosci. 2003, 17:2065-2076.
26. van Vliet E.A., da Costa Araujo S., Redeker S., van Schaik R., Aronica E., Gorter J.A. Blood-brain barrier leakage may lead to progression of temporal lobe epilepsy. Brain 2007, 130:521-534.
27. Vezzani A., French J., Bartfai T., Baram T.Z. The role of inflammation in epilepsy. Nat. Rev. Neurol. 2011, 7:31-40.
28. Vezzani, A., Friedman, A., Dingledine, R.J., in press. The role of inflammation in epileptogenesis. Neuropharmacology (Apr 13 EPub ahead of Print). http://dx.doi.org/10.1016/j.neuropharm.2012.04.004.
29. Wang D.B., Dayton R.D., Henning P.P., Cain C.D., Zhao L.R., Schrott L.M., Orchard E.A., Knight D.S., Klein R.L. Expansive gene transfer in the rat CNS rapidly produces amyotrophic lateral sclerosis relevant sequelae when TDP-43 is overexpressed. Mol. Ther. 2010, 18:2064-2074.
30. Weinberg M.S., Blake B.L., Samulski R.J., McCown T.J. The influence of epileptic neuropathology and prior peripheral immunity on CNS transduction by rAAV2 and rAAV5. Gene Ther. 2011, 18:961-968.
31. Wright J.L., Merchant R.E. Histopathological effects of intracerebral injections of 587 human recombinant tumor necrosis factor-alpha in the rat. Acta Neuropathol. 1992, 85(588):93-100.
32. Wu Y., Wang X., Mo X., Xi Z., Xiao F., Li J., Zhu X., Luan G., Wang Y., Li Y., Zhang J. Expression of monocyte chemoattractant protein-1 in brain tissue of patients with intractable epilepsy. Clin. Neuropathol. 2008, 27:55-63.
33. Yamamoto A., Schindler C.K., Murphy B.M., Bellver-Estelles C., So N.K., Taki W., Meller R., Simon R.P., Henshall D.C. Evidence of tumor necrosis factor receptor 1 signaling in human temporal lobe epilepsy. Exp. Neurol. 2006, 202:410-420.